Welcome to our dedicated page for Merit Med Sys news (Ticker: MMSI), a resource for investors and traders seeking the latest updates and insights on Merit Med Sys stock.
Merit Medical Systems, Inc. (NASDAQ: MMSI) delivers essential updates for stakeholders tracking innovations in minimally invasive medical devices. This dedicated news hub provides verified information about the company's advancements in cardiology, radiology, and vascular access technologies.
Investors and healthcare professionals will find timely updates on regulatory milestones, product launches, and strategic initiatives. Our curated collection includes earnings reports, clinical trial developments, and partnership announcements that shape Merit Medical's position in the $450B+ global medical device market.
Key coverage areas include new FDA clearances for diagnostic catheters, financial performance across international markets, and innovations in embolization technologies. All content undergoes strict verification to ensure compliance with financial reporting standards and medical industry regulations.
Bookmark this page for direct access to Merit Medical's latest developments in interventional radiology tools, quarterly financial disclosures, and executive leadership updates. For real-time alerts on critical announcements, subscribe to our validated news feed.
Merit Medical Systems (MMSI) reported Q1 2023 revenue of $297.6 million, marking an 8.0% increase from Q1 2022. Constant currency revenue grew 9.8% year-over-year, driven by performance in U.S. and international markets. The GAAP operating margin improved to 8.9% compared to 5.5% in Q1 2022, while non-GAAP operating margin rose to 16.1%. Q1 GAAP EPS was $0.36, up from $0.18 the previous year. CEO Fred Lampropoulos highlighted the strong start to FY 2023, updating financial guidance with projected revenue between $1.217 billion and $1.229 billion. Positive outlook includes expectations of 5%-6% growth in the cardiovascular segment and earnings per share of $1.71 to $1.79 by year-end. Cash and equivalents stood at $57.9 million, with total debt obligations of $197.8 million.